Patent Assignment
Reel/Frame 073038/0391
Assignment of Assignor's Interest
Recorded: 2025-11-25
Pages: 3
Assignee
CHEMOCENTRYX, INC.
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CALIFORNIA, 91320-1799
Covered Property
(1)
Combination Therapy Using a Chemokine Receptor 2 (CCR2) Antagonist and a Pd-1 and/or Pd-L1 Inhibitor
Application:
18/311,815 →
Publication:
US 2023/0404986